Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_assertion type Assertion NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_head.
- NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_assertion description "[Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_provenance.
- NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_assertion evidence source_evidence_literature NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_provenance.
- NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_assertion SIO_000772 19486012 NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_provenance.
- NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_assertion wasDerivedFrom befree-20150227 NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_provenance.
- NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_assertion wasGeneratedBy ECO_0000203 NP831188.RAgTNY3WVRnVQ3bgTE_QhOdu6fmi9k_HST2C_tFp6_sTU130_provenance.